TA-1 (Thymosin Alpha-1)

Clinically-documented immune-modulating thymic peptide.

Thymosin Alpha-1 is a 28-amino acid peptide isolated from thymosin fraction 5 of bovine thymus. It is among the most clinically documented immunomodulatory peptides, with approved clinical uses in multiple countries. Research covers T-cell maturation, dendritic cell function, innate immune amplification, and adjuvant applications in oncology models.

Research Applications

• T-cell maturation & activation
• Dendritic cell function modulation
• Innate & adaptive immunity research
• Hepatitis/viral infection models
• Oncology immunotherapy adjuvant studies